Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
165.86
+1.63 (+0.99%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
99
100
Next >
Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists
January 30, 2024
This virtually unknown company has been paying a consecutive dividend to its investors for more than 200 years.
Via
The Motley Fool
3 Perfect Stocks for Retirees to Buy Hand Over Fist in the New Bull Market
January 30, 2024
These industry-leading, time-tested companies are ideal for retired investors.
Via
The Motley Fool
Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
January 29, 2024
Team up with the schoolyard bully so to speak with these compelling ideas for hedge fund favorite stocks to buy.
Via
InvestorPlace
Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done'
January 29, 2024
J&J settles opioid lawsuit with Washington state for $149.5 million in one lump sum, giving more resources to fight the fentanyl crisis.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
January 27, 2024
These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?
Via
The Motley Fool
The Analyst Verdict: Johnson & Johnson In The Eyes Of 12 Experts
January 24, 2024
Via
Benzinga
Why Johnson & Johnson Stock Was Pulling Back Today
January 23, 2024
The healthcare giant matched estimates, but it wasn't enough to please investors.
Via
The Motley Fool
Should You Buy the Dogs of the Dow in 2024?
January 27, 2024
The popular dividend-investing strategy has been around for years. Is it right for you?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year
January 26, 2024
Investing in dividend stocks with consistent cash flow will help build a portfolio that generates passive income throughout 2024.
Via
InvestorPlace
Stock Market Continues To Rally; ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review
January 26, 2024
The S&P 500 and Dow Jones hit fresh record highs on Friday.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Elliott Wave Technical Analysis: Johnson & Johnson - Friday, Jan. 26
January 26, 2024
Looking for a break of {b} of 2 to enter long.
Via
Talk Markets
Abbott Laboratories on track for new highs in 2024
January 25, 2024
Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact.
Via
MarketBeat
Exposures
COVID-19
Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon
January 25, 2024
Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.
Via
The Motley Fool
Intuitive Surgical’s post-earnings dip is a healthy time to buy
January 25, 2024
Intuitive Surgical had a solid quarter, but strength was expected, and the stock sold off; a healthy correction is good, but will investors buy the dip?
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
7 Dividend Stocks to Buy and Never Sell: January 2024 Edition
January 25, 2024
Seeking out dividend stocks to buy and hold is a time-tested strategy that has proved itself in all types of markets
Via
InvestorPlace
Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
January 24, 2024
FDA issues classwide black box warning for CAR-T therapies due to T-cell cancer risk. Drops Gilead's cell therapy from the list.
Via
Benzinga
Exposures
Product Safety
What's Going On Johnson & Johnson Stock Today?
January 24, 2024
JNJ reports strong earnings, beats expectations for Q4 of 2023, with increased sales and successful acquisitions. Stock closes lower, settles talc litigation, and delays competitor's launch.
Via
Benzinga
Topics
Earnings
Exposures
Financial
Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks
January 24, 2024
Earnings have served to mitigate early January's weakness, and sentiment appears to be upbeat going into Wednesday's session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High
January 24, 2024
The CNN Money Fear and Greed index showed a further increase in overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Stocks To Consider After Beating Earnings Estimates
January 23, 2024
With the earnings season now in full force, valuable data to gauge the broader economy will be rolling in. I will share three stocks that posted earnings beats this morning, and that I think may be...
Via
Talk Markets
Topics
Earnings
Economy
Exposures
Economy
Financial
Your Guide To Volatile Earnings This Week - NFLX On The Move
January 23, 2024
This week we get to play some earnings trades as earnings season begins for 2024. We're seeing Netflix rally immediately after hours on its earnings as we plot its expected move for tomorrow and...
Via
Talk Markets
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
January 23, 2024
JNJ earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?
January 23, 2024
Wall Street took a breather on Tuesday, with the major U.S. stock indices trading near the flatline or showing slight declines during midday trading in New York as investors closely await a series of...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Johnson & Johnson's Settlement For Talc Cancer Lawsuits Reaches $700M Settlement With US States
January 23, 2024
Johnson & Johnson settles state investigations for $700 million, addressing alleged talc product safety issues linked to cancer.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
What's Going On With Danish Healthcare Firm Genmab Stock?
January 23, 2024
Genmab's legal update on Darzalex: Arbitrator dismisses bid for milestone payments. Despite this, diverse revenue sources, including royalty agreements, contribute to strong growth.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via
Benzinga
US Stocks Mixed; Johnson & Johnson Posts Upbeat Earnings
January 23, 2024
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 90 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 37,915.41 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Johnson & Johnson's Clock 12% Q4 Revenue Growth, Cancer and Crohn's Disease Drugs Account as Largest Sellers
January 23, 2024
Johnson & Johnson's Q4 2023 performance, with adjusted earnings up 11.7%, sales at $21.4 billion, and key insights into pharmaceutical and MedTech segments.
Via
Benzinga
Why J&J's Narrow Fourth-Quarter Beat Is A Blessing For Medtech
January 23, 2024
The company's medtech sales easily beat expectations, which bodes well for medtech stocks.
Via
Investor's Business Daily
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.